Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients

Purpose. The predominant cause of mortality in dialysis patients are cardiovascular events. Platelet and monocyte activity markers play an important role in cardiovascular mortality and were assessed and related to dialysis quality criteria in haemodialysis (HD) and peritoneal dialysis (PD) patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Ksenija Stach, Susanne Karb, Ibrahim Akin, Martin Borggrefe, Bernhard Krämer, Thorsten Kälsch, Anna-Isabelle Kälsch
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/8506072
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567368381890560
author Ksenija Stach
Susanne Karb
Ibrahim Akin
Martin Borggrefe
Bernhard Krämer
Thorsten Kälsch
Anna-Isabelle Kälsch
author_facet Ksenija Stach
Susanne Karb
Ibrahim Akin
Martin Borggrefe
Bernhard Krämer
Thorsten Kälsch
Anna-Isabelle Kälsch
author_sort Ksenija Stach
collection DOAJ
description Purpose. The predominant cause of mortality in dialysis patients are cardiovascular events. Platelet and monocyte activity markers play an important role in cardiovascular mortality and were assessed and related to dialysis quality criteria in haemodialysis (HD) and peritoneal dialysis (PD) patients. Methods. For this prospective comparative study, HD patients (n=41) and PD patients (n=10) were included. In whole blood samples, surface expression of CD62P and CD40L on platelets, tissue factor binding on monocytes, and platelet-monocyte aggregates were measured by flow cytometry. Plasma levels of MCP-1, IL-6, TNFα, and soluble CD40L were analysed by enzyme-linked immunosorbent assay. Results. Haemodialysis patients showed a significantly higher CD62P expression on platelets (p=0.017), significantly higher amount of platelet-monocyte aggregates (p<0.0001), and significantly more tissue factor binding on monocytes (p<0.0001) compared to PD patients. In PD patients, a significant correlation between Kt/V and platelet CD40L expression (r=0.867; 0.001) and between Kt/V and platelet CD62P expression (r=0.686; p=0.028) was observed, while there was no significant correlation between Kt/V and tissue factor binding on monocytes and platelet-monocyte aggregates, respectively. Conclusion. Platelet and monocyte activity markers are higher in HD patients in comparison with those in PD patients, possibly suggesting a higher risk of cardiovascular morbidity and mortality.
format Article
id doaj-art-4ca15ca9fc6b453a90a69e94d3328e96
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-4ca15ca9fc6b453a90a69e94d3328e962025-02-03T01:01:36ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/85060728506072Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis PatientsKsenija Stach0Susanne Karb1Ibrahim Akin2Martin Borggrefe3Bernhard Krämer4Thorsten Kälsch5Anna-Isabelle Kälsch61st Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany1st Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany1st Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany1st Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany5th Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany1st Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany5th Medical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, GermanyPurpose. The predominant cause of mortality in dialysis patients are cardiovascular events. Platelet and monocyte activity markers play an important role in cardiovascular mortality and were assessed and related to dialysis quality criteria in haemodialysis (HD) and peritoneal dialysis (PD) patients. Methods. For this prospective comparative study, HD patients (n=41) and PD patients (n=10) were included. In whole blood samples, surface expression of CD62P and CD40L on platelets, tissue factor binding on monocytes, and platelet-monocyte aggregates were measured by flow cytometry. Plasma levels of MCP-1, IL-6, TNFα, and soluble CD40L were analysed by enzyme-linked immunosorbent assay. Results. Haemodialysis patients showed a significantly higher CD62P expression on platelets (p=0.017), significantly higher amount of platelet-monocyte aggregates (p<0.0001), and significantly more tissue factor binding on monocytes (p<0.0001) compared to PD patients. In PD patients, a significant correlation between Kt/V and platelet CD40L expression (r=0.867; 0.001) and between Kt/V and platelet CD62P expression (r=0.686; p=0.028) was observed, while there was no significant correlation between Kt/V and tissue factor binding on monocytes and platelet-monocyte aggregates, respectively. Conclusion. Platelet and monocyte activity markers are higher in HD patients in comparison with those in PD patients, possibly suggesting a higher risk of cardiovascular morbidity and mortality.http://dx.doi.org/10.1155/2017/8506072
spellingShingle Ksenija Stach
Susanne Karb
Ibrahim Akin
Martin Borggrefe
Bernhard Krämer
Thorsten Kälsch
Anna-Isabelle Kälsch
Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients
Mediators of Inflammation
title Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients
title_full Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients
title_fullStr Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients
title_full_unstemmed Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients
title_short Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients
title_sort elevation of platelet and monocyte activity markers of atherosclerosis in haemodialysis patients compared to peritoneal dialysis patients
url http://dx.doi.org/10.1155/2017/8506072
work_keys_str_mv AT ksenijastach elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients
AT susannekarb elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients
AT ibrahimakin elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients
AT martinborggrefe elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients
AT bernhardkramer elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients
AT thorstenkalsch elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients
AT annaisabellekalsch elevationofplateletandmonocyteactivitymarkersofatherosclerosisinhaemodialysispatientscomparedtoperitonealdialysispatients